Powered by 
Technavio
Ventria Bioscience | Data-Driven Analysis and Industry Review
Published: August 28, 2024Ventria Bioscience is a leading biotechnology company specializing in the production of recombinant proteins using its proprietary plant-based expression system. The company's mission is to develop and commercialize innovative, sustainable, and cost-effective solutions for the production of high-value proteins for the pharmaceutical, nutritional, and agricultural industries. Ventria's plant-made protein technology allows for the production of complex proteins that are difficult or impossible to make using traditional methods. The company's flagship product, Ventria Gold®, is a plant-derived, hypoallergenic soy protein used in food and pharmaceutical applications. Ventria Bioscience is committed to advancing science and technology to improve human and animal health and well-being while minimizing the environmental impact of production processes.'
1. Specializes in the production of recombinant proteins using its proprietary plant-based expression system, which allows for large-scale, cost-effective production of complex proteins.
2. Offers a range of products for various industries, including pharmaceuticals, animal health, and agriculture, with a focus on producing proteins that are difficult or impossible to produce using traditional methods.
3. Collaborates with industry leaders and academic institutions to develop and commercialize new proteins and applications, leveraging its expertise in plant-based expression and protein engineering.
4. Utilizes a cGMP manufacturing facility to ensure the production of high-quality, consistent proteins for use in regulated applications.
5. Has a strong intellectual property portfolio, with over 300 patents and patent applications, protecting its technology and products in the market.
1. Ventria Bioscience specializes in the production of plant-based, recombinant proteins for use in the pharmaceutical and biotechnology industries.
2. They employ proprietary technology to produce proteins in rice, creating a sustainable and cost-effective alternative to traditional methods using animal or microbial systems.
3. Their portfolio includes a range of therapeutic proteins, including human serum albumin, interferon, and monoclonal antibodies, which are used in various medical applications such as wound healing, vaccine adjuvants, and protein replacement therapy.
4. Ventria Bioscience's business intelligence capabilities include market analysis, competitive intelligence, and strategic planning, enabling them to identify trends and opportunities in the biotech industry and respond effectively to market demands.
5. The company also offers contract manufacturing services, providing customized production solutions for clients seeking to bring their own recombinant proteins to market.
Browse Our Research Portfolio In Ventria Bioscience Markets
Health Care
Health Care
Pharmaceuticals
Pharmaceuticals
Pharmaceuticals
Pharmaceuticals
About Technavio
With unparalleled market insights, our research is designed to elevate your business to new heights. Technavio stands at the forefront of market research with a global perspective. Our approach is grounded in four key principles: accessible reports, comprehensive industry analysis, a focus on innovative and emerging technologies, and competitive pricing. We are dedicated to empowering companies and executives to make informed, timely, and strategic decisions.
